What is Neurona Therapeutics worth?
$1.1Blast known valuation
Neurona Therapeutics last raised $101.7M in its Later Stage VC (Series F) (Mar 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Neurona Therapeutics
Create free account
No card required
Funding history
6 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2025 | Later Stage VC (Series F) | $101.7M | ▮ | ▮ |
| Feb 2024 | Later Stage VC (Series E) | $120.0M | ▮ | ▮ |
| Mar 2021 | Later Stage VC | $72.0M | ▮ | ▮ |
| Nov 2019 | Early Stage VC | $15.0M | ▮ | ▮ |
| Feb 2018 | Early Stage VC | $10.0M | ▮ | ▮ |
| Dec 2014 | Early Stage VC | $28.7M | ▮ | ▮ |
How Neurona Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Neurona Therapeutics, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Neurona Therapeutics worth?
- Neurona Therapeutics's implied valuation is $1.1B, based on the PA Mark composite price of about $3 per share as of Sep 2026.
- How much has Neurona Therapeutics raised?
- Neurona Therapeutics has raised $347.6M in total funding across 6 recorded rounds.
- When did Neurona Therapeutics last raise?
- Neurona Therapeutics last raised in Mar 2025 (Later Stage VC (Series F)), raising $101.7M.